AlanSubie4Life
Efficiency Obsessed Member
More info in the release for anyone interested (I haven't reviewed in detail yet).
Maybe you should have?:
"The researchers used a rapid antibody test for the study. The FDA allows such tests for public health surveillance to gain greater clarity on actual infection rates. The test's accuracy was further assessed at a lab at Stanford University, using blood samples that were positive and negative for COVID-19.
In addition to Sood and Simon, other authors and institutions contributing to the study include Peggy Ebner of the Keck School; Daniel Eichner of the Sports Medicine Research & Testing Laboratory; Jeffrey Reynolds of LRW Group; Eran Bendavid and Jay Bhattacharya of Stanford University School of Medicine."
I'm going to assume they are using the same statistical "methods" they used from their last study in Santa Clara, until shown otherwise (I don't see their paper - why not provide the link in the press release?). Which means we should probably view their multiplier as a modest overestimate, until the analysis is complete and the specificity of the test is properly understood. A modest overestimate would likely put things in line with what we assume the prevalence to be.
Apparently these guys are undeterred by last week's fiasco. Maybe this time they confirmed the positives with ELISA testing?